Since 2006, Tarik Möröy, PhD, is the President and Scientific Director of the Institut de recherches cliniques de Montréal (IRCM), as well as Director of the Hematopoiesis and Cancer research unit and Full IRCM Research Professor. Since 2007, he holds the Canada Research Chair (Tier 1) in Hematopoiesis and Immune Cell Differentiation, which was renewed in 2014. He is also Full Research Professor at the Université de Montréal and adjunct professor at McGill University. Since his academic accreditation in 1991 in Germany, he has trained over 50 postdoctoral fellows and graduate students, directed several research networks and, until 2006, held several senior management positions in Germany.
As the IRCM’s President and Scientific Director, he provides leadership for 35 principal investigators. He is responsible for strategic planning; researcher recruitment (14 new researchers were recruited since 2007); the institute’s funding; university, hospital and government relations; training, public communications and education; operations of the IRCM clinic; and overseeing the budget of one of Canada’s leading biomedical research institutions. Under his management, the IRCM vastly expanded its technical core facilities services and created a graduate program focused on translational research in order to bridge the gap between basic laboratory research and the needs of the clinical practice, thus accelerating the shift towards personalized medicine. These initiatives centered around the desire to “provide passionate researchers with the ideal conditions to experiment with their boldest ideas, test their theories and pave their own way for the benefit of us all.”
Dr. Möröy has authored more than 280 publications, including 152 original articles and reviews in specialized journals, as well as over 120 contributions to scientific meetings. In 2014, he received a recognition award from the Leukemia and Lymphoma Society. He was elected to the Board of Directors of the Canadian Society for Molecular Biosciences in 2015 and to the Board of Directors of Research Canada in 2016. He was also appointed “Honorary Guest Professor” by the Capital University in Beijing for his outstanding achievements in immunology in 2015..
For more information, download his complete biography.